[{"address1": "1111 Main Street", "address2": "Suite 660", "city": "Vancouver", "state": "WA", "zip": "98660", "country": "United States", "phone": "360 980 8524", "fax": "360 799 5954", "website": "https://www.cytodyn.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "CytoDyn Inc., a clinical-stage biotechnology company, develops treatments for multiple therapeutic indications. It is involved in the clinical development of leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19. The company's leronlimab is currently under phase 2 development for the treatment of micro-satellite stable colorectal cancer, and solid tumors in oncology, such as metastatic triple-negative breast cancer. The company was formerly known as RexRay Corporation. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington.", "fullTimeEmployees": 13, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jacob P. Lalezari M.D.", "age": 64, "title": "Chief Executive Officer", "yearBorn": 1960, "fiscalYear": 2025, "totalPay": 441850, "exercisedValue": 0, "unexercisedValue": 274500}, {"maxAge": 1, "name": "Mr. Robert E. Hoffman B.B.A., CPA", "age": 58, "title": "Chief Financial Officer", "yearBorn": 1966, "fiscalYear": 2025, "totalPay": 444440, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tyler  Blok", "age": 37, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1987, "fiscalYear": 2025, "totalPay": 389994, "exercisedValue": 0, "unexercisedValue": 141596}, {"maxAge": 1, "name": "Dr. Bernie  Cunningham P.M.P., Ph.D.", "title": "Vice President of Operations", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Cyrus  Arman M.B.A., Ph.D.", "age": 42, "title": "Senior Vice President of Business Operations", "yearBorn": 1982, "fiscalYear": 2025, "totalPay": 278100, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Scott  Hansen Ph.D.", "title": "Head of Research & Basic Science", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Max  Lataillade D.O., M.P.H.", "title": "Senior VP & Head of Clinical Development", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Cristina  De Leon", "title": "Investors", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1767139200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.25, "open": 0.2496, "dayLow": 0.249, "dayHigh": 0.2696, "regularMarketPreviousClose": 0.25, "regularMarketOpen": 0.2496, "regularMarketDayLow": 0.249, "regularMarketDayHigh": 0.2696, "payoutRatio": 0.0, "beta": 1.372, "forwardPE": -1.5, "volume": 477522, "regularMarketVolume": 477522, "averageVolume": 1852935, "averageVolume10days": 1393550, "averageDailyVolume10Day": 1393550, "bid": 0.26, "ask": 0.265, "bidSize": 51946, "askSize": 42500, "marketCap": 340892256, "fiftyTwoWeekLow": 0.1, "fiftyTwoWeekHigh": 0.49, "allTimeHigh": 10.01, "allTimeLow": 0.06, "fiftyDayAverage": 0.268, "twoHundredDayAverage": 0.28155, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 351807552, "profitMargins": 0.0, "floatShares": 1259589232, "sharesOutstanding": 1262563778, "heldPercentInsiders": 0.00013, "heldPercentInstitutions": 0.00021, "impliedSharesOutstanding": 1262563779, "bookValue": -0.079, "lastFiscalYearEnd": 1748649600, "nextFiscalYearEnd": 1780185600, "mostRecentQuarter": 1756598400, "netIncomeToCommon": -22506000, "trailingEps": -0.02, "forwardEps": -0.18, "enterpriseToEbitda": 48.319, "52WeekChange": 1.25, "SandP52WeekChange": 0.14261019, "quoteType": "EQUITY", "currentPrice": 0.27, "recommendationKey": "none", "totalCash": 9332000, "totalCashPerShare": 0.007, "ebitda": 7281000, "totalDebt": 27305000, "quickRatio": 0.134, "currentRatio": 0.192, "returnOnAssets": 0.21877001, "freeCashflow": 4271375, "operatingCashflow": -16655000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CYDY", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "corporateActions": [], "regularMarketTime": 1763154000, "exchange": "OQB", "messageBoardId": "finmb_10039157", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 8.000004, "regularMarketPrice": 0.27, "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1166020200000, "regularMarketChange": 0.02000001, "regularMarketDayRange": "0.249 - 0.2696", "fullExchangeName": "OTC Markets OTCQB", "averageDailyVolume3Month": 1852935, "fiftyTwoWeekLowChange": 0.17000002, "fiftyTwoWeekLowChangePercent": 1.7000002, "fiftyTwoWeekRange": "0.1 - 0.49", "fiftyTwoWeekHighChange": -0.22, "fiftyTwoWeekHighChangePercent": -0.4489796, "fiftyTwoWeekChangePercent": 125.0, "shortName": "CytoDyn Inc.", "longName": "CytoDyn Inc.", "marketState": "CLOSED", "earningsTimestampStart": 1768397400, "earningsTimestampEnd": 1768397400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.02, "epsForward": -0.18, "fiftyDayAverageChange": 0.002000004, "fiftyDayAverageChangePercent": 0.0074627013, "twoHundredDayAverageChange": -0.011549979, "twoHundredDayAverageChangePercent": -0.041022837, "priceToBook": -3.4177215, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "displayName": "CytoDyn", "trailingPegRatio": null, "__fetch_time": "2025-11-15"}]